These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 10026704
21. How to improve the cardiac prognosis for diabetes. Herlitz J, Malmberg K. Diabetes Care; 1999 Mar; 22 Suppl 2():B89-96. PubMed ID: 10097907 [Abstract] [Full Text] [Related]
22. Management of dyslipidemia in adults with diabetes. American Diabetes Association. Diabetes Care; 1998 Jan; 21(1):179-82. PubMed ID: 9538989 [No Abstract] [Full Text] [Related]
24. [A change of attitude in lipidology, achievement of target levels. What comes next?]. Márk L, Dani G, Kiss Z, Katona A. Orv Hetil; 2008 Sep 14; 149(37):1731-6. PubMed ID: 18805756 [Abstract] [Full Text] [Related]
25. Statins and renal function in patients with diabetes mellitus. Athyros VG, Papageorgiou AA, Elisaf M, Mikhailidis DP, GREACE Study Collaborative Group. Curr Med Res Opin; 2003 Sep 14; 19(7):615-7. PubMed ID: 14606984 [Abstract] [Full Text] [Related]
28. The burden of hyperlipidaemia and diabetes in cardiovascular diseases. Merkler M, Reiner Z. Fundam Clin Pharmacol; 2007 Nov 14; 21 Suppl 2():1-3. PubMed ID: 18001311 [Abstract] [Full Text] [Related]
29. Treatment of lipids and type 2 diabetes. Hermayer KL. Curr Cardiol Rep; 2004 Nov 14; 6(6):443-50. PubMed ID: 15485606 [Abstract] [Full Text] [Related]
30. Primary prevention of coronary heart disease: where do we go from here? Gotto AM. Arch Intern Med; 2001 Apr 09; 161(7):922-4. PubMed ID: 11295953 [No Abstract] [Full Text] [Related]
31. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology). Esselstyn CB. Am J Cardiol; 1999 Aug 01; 84(3):339-41, A8. PubMed ID: 10496449 [Abstract] [Full Text] [Related]
32. [Therapeutic management of the dyslipidemic patient]. Agence Française de Sécurité Sanitaire des Produits de Santé. Ann Endocrinol (Paris); 2001 Feb 01; 62(1 Pt 1):70-5. PubMed ID: 11240406 [No Abstract] [Full Text] [Related]
33. Hyperlipidemia. When does treatment make a difference? Wise GR, Schultz TT. Postgrad Med; 1996 Jul 01; 100(1):138-49. PubMed ID: 8668612 [Abstract] [Full Text] [Related]
34. Hyperlipidaemia and coronary risk. The Scottish Lipid Consensus Group. Scott Med J; 1991 Aug 01; 36(4):99-103. PubMed ID: 1815558 [No Abstract] [Full Text] [Related]
35. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations]. Idzior-Waluś B. Przegl Lek; 1999 Aug 01; 56(5):372-6. PubMed ID: 10554575 [Abstract] [Full Text] [Related]
36. Efficacy and safety of cholesterol-lowering treatment. Abraha I, Bonacini I, Montedori A. Lancet; 2006 Feb 11; 367(9509):469; author reply 470-1. PubMed ID: 16473116 [No Abstract] [Full Text] [Related]
37. New strategies for the treatment of diabetic dyslipidemia. Haffner SM, Goldberg RB. Diabetes Care; 2002 Jul 11; 25(7):1237-9. PubMed ID: 12087025 [No Abstract] [Full Text] [Related]
38. Practical drug therapy for common hyperlipidaemias. Tikkanen MJ. Baillieres Clin Endocrinol Metab; 1990 Dec 11; 4(4):719-42. PubMed ID: 2082904 [No Abstract] [Full Text] [Related]
39. Primary prevention of ischaemic heart disease with lipid-lowering drugs. Lancet; 1988 Feb 13; 1(8581):333-4. PubMed ID: 2893141 [No Abstract] [Full Text] [Related]
40. Lipid-lowering drugs in the management of hyperlipidaemia. Bhatnagar D. Pharmacol Ther; 1998 Sep 13; 79(3):205-30. PubMed ID: 9776377 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]